Skip to main content
. 2022 Jul 13;13:946825. doi: 10.3389/fimmu.2022.946825

Table 1.

Clinical and Laboratory Characteristics in Patients With GBS and Healthy Controls .

Controls Patients with GBS
Characteristics N=153 N=147 t/z/x2 P value
Demographic
Age,y 47.0 (31.5-60.0) 48.0 (33.0-60.0) -0.535 0.592
Sex,male 85 (55.6) 82 (55.8) 0.002 0.968
Medical history, n (%)
Hypertension 36 (23.5) 39 (26.5) 0.360 0.548
Diabetes mellitus 25 (16.3) 19 (12.9) 0.698 0.403
Heart disease 12 (7.8) 9 (6.1) 0.341 0.559
Cigarette smoking 25 (16.3) 41 (27.9) 6.487 0.011
Alcohol consumption 16 (10.5) 36 (24.5) 10.302 0.001
Surgery 10 (6.5) 36 (24.5) 18.615 < 0.001
Trauma 1 (0.7) 19 (12.9) 18.114 < 0.001
Hyperlipidemia 15 (9.8) 11 (7.5) 0.510 0.475
Preceding infection 28 (18.3) 91 (61.9) 59.561 < 0.001
Clinical features
SBP, mmHg 119.86 ± 15.19 133.44 ± 17.32 -9.858 < 0.001
DBP, mmHg 72.42 ± 9.72 84.22 ± 11.00 -7.226 < 0.001
BMI, kg/m2 23.50 (20.85-25.60) 24.22 (21.48-26.45) -2.104 0.035
Laboratory results
Triglyceride, mmol/L 0.88 (0.63-1.21) 1.24 (0.88-1.93) -6.838 < 0.001
Total cholesterol, mmol/L 4.41 ± 0.69 4.20 ± 0.87 2.315 0.021
HDL cholesterol, mmol/L 1.56 (1.37-1.78) 1.09 (0.93-1.25) -11.175 < 0.001
LDL cholesterol, mmol/L 2.48 ± 0.66 2.55 ± 0.78 -0.831 0.406
Remnant cholesterol, mmol/L 0.36 (0.29-0.43) 0.49 (0.37-0.62) -6.949 < 0.001
ApoA1, g/L 1.49 (1.35-1.63) 1.14 (1.02-1.28) -10.902 < 0.001
ApoB, g/L 0.74 ± 0.17 0.89 ± 0.21 -6.779 < 0.001
Homocysteine, μmol/L 7.60 (6.79-8.41) 11.01 (8.70-12.69) -10.450 < 0.001
Dyslipidemia index, n (%) 95.223 < 0.001
0 110 (71.9) 27 (18.4)
1 20 (13.1) 44 (29.9)
2 22 (14.4) 45 (30.6)
≥3 1 (0.6) 31 (21.1)

Data presented as mean ± SD, median (Q1-Q3) or percentage. DBP, diastolic blood pressure; SBP, systolic blood pressure; BMI, Body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; GBS, Guillain-Barré syndrome; APOA1, apolipoprotein A1; APOB, apolipoprotein B.